SCHEMBL9036136

SCHEMBL9036136

FC(F)(F)c1cc(CS)cc(CCOC2OCCNC2c2ccccc2)c1

nearest known ligand 0.69

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TACR1 P25103 17/20 0.69
TP53 P04637 2/20 0.47
CYP1A2 P05177 2/20 0.47
CYP3A4 P08684 2/20 0.47
CYP2D6 P10635 2/20 0.47
TSHR P16473 2/20 0.47
MEN1 O00255 2/20 0.47
KMT2A Q03164 2/20 0.47
MAPT P10636 1/20 0.47
CYP2C9 P11712 1/20 0.47
CYP2C19 P33261 1/20 0.47
THPO P40225 1/20 0.47
HSD17B10 Q99714 1/20 0.47
GMNN O75496 1/20 0.47
LMNA P02545 1/20 0.47
PMP22 Q01453 1/20 0.47
SMN1; SMN2 Q16637 1/20 0.47
NPSR1 Q6W5P4 1/20 0.47
TACR2 P21452 1/20 0.38
TACR3 P29371 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9035451 0.93 TACR1 (0.79) TACR1TP53CYP1A2CYP3A4CYP2D6
SCHEMBL9084405 0.93 TACR1 (0.79) TACR1TP53CYP1A2CYP3A4CYP2D6
SCHEMBL8555818 0.93 TACR1 (0.79) TACR1TP53CYP1A2CYP3A4CYP2D6
SCHEMBL9035598 0.89 TACR1 (0.70) TACR1TP53CYP1A2CYP3A4CYP2D6
SCHEMBL9035590 0.89 TACR1 (0.70) TACR1TP53CYP1A2CYP3A4CYP2D6
SCHEMBL9036122 0.88 TACR1 (0.72) TACR1TP53CYP1A2CYP3A4CYP2D6
SCHEMBL9036118 0.88 TACR1 (0.72) TACR1TP53CYP1A2CYP3A4CYP2D6
SCHEMBL9036127 0.86 TACR1 (0.66) TACR1TP53CYP1A2CYP3A4CYP2D6
SCHEMBL9055364 0.84 TACR1 (0.63) TACR1TP53CYP1A2CYP3A4CYP2D6
SCHEMBL9055369 0.84 TACR1 (0.63) TACR1TP53CYP1A2CYP3A4CYP2D6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0734381-A1 MORPHOLINE AND THIOMORPHOLINE TACHYKININ RECEPTOR ANTAGONISTS MERCK & CO. INC. (US) 1996-10-02 EP claimed
US-5512570-A Treatment of emesis with morpholine tachykinin receptor antagonists MERCK & CO., INC. (US) 1996-04-30 US disclosed